Cargando…

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Corrigenda
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917302/ https://www.ncbi.nlm.nih.gov/pubmed/31846573 http://dx.doi.org/10.1002/acn3.50955

Ejemplares similares

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

Increased levels of neurofilament light chain in suicide attempters’ serum
por: Ramezani, Mahtab, et al.
Publicado: (2022)

Prediabetes is associated with a higher serum neurofilament light chain level in adolescents
por: Chen, Zheng, et al.
Publicado: (2023)

Factors influencing serum neurofilament light chain levels in normal aging
por: Koini, Marisa, et al.
Publicado: (2021)

Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
por: Chitnis, Tanuja, et al.
Publicado: (2018)

Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia
por: Ma, Weibin, et al.
Publicado: (2020)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
por: Sjölin, Karl, et al.
Publicado: (2022)

White matter hyperintensity, neurofilament light chain, and cognitive decline
por: Dhana, Anisa, et al.
Publicado: (2022)

Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden
por: Duering, Marco, et al.
Publicado: (2018)

Serum neurofilament light chain level as a predictor of cognitive stage transition
por: Lee, Eun-Hye, et al.
Publicado: (2022)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Serum neurofilament light chains in MS: Association with the Timed Up and Go
por: Allali, Gilles, et al.
Publicado: (2020)

Corrigendum: Light-matter decoupling and A(2) term detection in superconducting circuits
por: García-Ripoll, J. J., et al.
Publicado: (2017)

Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study
por: Tavazzi, Eleonora, et al.
Publicado: (2020)

Serum neurofilament light chain levels are associated with early neurological deterioration in minor ischemic stroke
por: Li, Jie, et al.
Publicado: (2023)

Serum neurofilament light chain levels are associated with all-cause mortality in the general US population
por: Ciardullo, Stefano, et al.
Publicado: (2023)

A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users
por: Bavato, Francesco, et al.
Publicado: (2023)

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
por: Kušnierová, Pavlína, et al.
Publicado: (2019)

Serum neurofilament light chain is increased in hereditary spastic paraplegias
por: Wilke, Carlo, et al.
Publicado: (2018)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
por: Hayashi, Tomohiro, et al.
Publicado: (2021)

Enhancing the clinical value of serum neurofilament light chain measurement
por: Kosa, Peter, et al.
Publicado: (2022)

Serum neurofilament light chain measurements following nerve trauma
por: Wilcox, Matthew, et al.
Publicado: (2023)

Investigating Associations Between Inflammatory Biomarkers, Gray Matter, Neurofilament Light and Cognitive Performance in Healthy Older Adults
por: Karoly, Hollis C., et al.
Publicado: (2021)

Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis
por: Brenner, Juliette, et al.
Publicado: (2023)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

Association of admission serum levels of neurofilament light chain and in-hospital mortality in geriatric patients with COVID-19
por: Marchegiani, Francesca, et al.
Publicado: (2022)

Corrigendum: Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients
por: Di Buduo, Christian A., et al.
Publicado: (2016)

Serum neurofilament light chain withstands delayed freezing and repeated thawing
por: Altmann, Patrick, et al.
Publicado: (2020)

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
por: Thebault, Simon, et al.
Publicado: (2021)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Serum neurofilament light chain as a severity marker for spinocerebellar ataxia
por: Shin, Hye-Rim, et al.
Publicado: (2021)

Serum neurofilament light chain in COVID-19 and the influence of renal function
por: Körtvelyessy, Peter, et al.
Publicado: (2023)

The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia
por: Frempong, Bernice, et al.
Publicado: (2021)

Implications of extreme serum neurofilament light chain levels for the management of patients with relapsing multiple sclerosis
por: Engel, Sinah, et al.
Publicado: (2021)

Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment
por: Schoeberl, Florian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tchjoj2auibj2jlbmgu507hh8o